Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,901,513
+$146,263 QoQ
Shares Held
162,023
+21.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#700
of 2,821 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESTFIELD CAPITAL MANAGEMENT CO LP holds $691,252,397 across 8 Drug Manufacturers - General names. PFE ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
416,732 | $499,840,904 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,287,629 | $162,679,047 | |
| 3 | JNJ |
Johnson & Johnson
|
35,772 | $9,085,014 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,297 | $6,848,664 | |
| 5 | AMGN |
Amgen Inc
|
17,047 | $6,173,059 | |
| 6 | PFE |
Pfizer Inc
This page
|
162,023 | $3,901,513 | |
| 7 | ABBV |
AbbVie Inc.
|
7,854 | $1,976,380 | |
| 8 | NVO |
Novo Nordisk A S
|
15,599 | $747,816 |
All Filings in PFE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,901,513 | 162,023 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,755,250 | 133,734 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,434,606 | 137,936 | Shares | Sole | 2026-02-11 | |
| 2025-03-31 | $7,999,761 | 315,697 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $8,959,605 | 337,716 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $9,710,990 | 335,556 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,699,480 | 275,178 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,056,547 | 254,290 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||